AC Immune S.A.
AC Immune S.A. (ACIU) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
aciu · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$7.00
Consensus
$7.00
+211.1% upside
Low
$7.00
Median: $7 · Last Close: $2.25
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.14 | ↓ 5.00% |
1-day model range: $2.12–$2.15. Peak: $2.15 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACIU · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | BTIG | Maintains | Buy→Buy |
| 2026-03-16 | BTIG | Maintains | Buy→Buy |
| 2025-11-04 | BTIG | Maintains | Buy→Buy |
| 2025-09-08 | BTIG | Maintains | Buy→Buy |
| 2025-05-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-03 | HC Wainwright& Co. | Maintains | Buy→Buy |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on AC Immune S.A. (ACIU) stock. Of the recent 29 rating actions, 0 were upgrades and 1 were downgrades. 9 analysts currently cover ACIU.
Analyst Recommendation Trends
ACIU analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$32M
↓ 73.1% YoY
Revenue Next Year
$92M
↑ 189.7% YoY
EPS This Year
$-0.34
EPS Next Year
$0.21
↓ 160.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACIU EPS of $-0.34 for the current fiscal year, based on estimates from 2 analysts. The ACIU revenue forecast is $32M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ACIU stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACIU price target is $7.00 (+211.1% upside), with an analyst consensus of Buy.
The ACIU short-term stock prediction for tomorrow is $2.14 (-5.00%). The ACIU stock price prediction for 2027 estimates an average of $1. The ACIU stock prediction for 2030 projects a range of $1–$1.
AC Immune S.A. trades on NASDAQ under the ticker ACIU. The ACIU stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
ACIU forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month ACIU price target is $7.00, with a high forecast of $7.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +211.1% potential upside from the current price of $2.25.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.